Covalon Technologies Ltd. (COV : TSX-V)
Common Stock
$4.46
CAD
-0.04 (-0.89%)
Last updated: 2026-10-29
Follow COV
COV
Covalon Technologies Ltd.
WealthAwesomePerformance
1 Day
-0.89%
1 Week
+11.50%
1 Month
+5.69%
YTD
+138.50%
Key Statistics
Market Cap
$124.28M
52W High
$4.59
52W Low
$1.55
P/E Ratio
28.13
50 Day MA
$3.59
200 Day MA
$2.36
Beta
0.17
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/29/2026 | $4.50 | $4.50 | $4.46 | $4.46 | $4.46 | 8,035 |
| 10/28/2026 | $4.40 | $4.50 | $4.39 | $4.50 | $4.50 | 17,792 |
| 10/27/2026 | $4.29 | $4.50 | $4.29 | $4.39 | $4.39 | 41,380 |
| 10/26/2026 | $4.19 | $4.27 | $4.19 | $4.22 | $4.22 | 6,230 |
| 10/23/2026 | $4.19 | $4.20 | $4.03 | $4.13 | $4.13 | 10,847 |
| 10/22/2026 | $3.89 | $4.02 | $3.89 | $4.00 | $4.00 | 3,272 |
| 10/21/2026 | $4.32 | $4.32 | $4.14 | $4.17 | $4.17 | 8,149 |
| 10/20/2026 | $3.85 | $4.36 | $3.85 | $4.33 | $4.33 | 11,237 |
| 10/19/2026 | $4.03 | $4.09 | $3.90 | $3.92 | $3.92 | 15,523 |
| 10/16/2026 | $4.05 | $4.05 | $4.00 | $4.03 | $4.03 | 28,209 |
Analyst Price Targets
Based on analyst covering COV · as of Oct 23, 2026
Wall Street analysts forecast COV stock price to rise 5.4% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$4.70
+5.4% Upside
Previously C$2.90 on Sep 17, 2026
Current Price
C$4.46
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on COV's historical volatility
30-Day Vol
89.5%
Annualized
90-Day Vol
74.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$5.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.73 | C$3.48 – C$6.45 |
| 60 trading days | C$5.02 | C$3.25 – C$7.78 |
| 90 trading days | C$5.33 | C$3.12 – C$9.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre- and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers a medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, perioperative dressings, silicone dressings, vascular access line guards, and wound dressings; and surgical, peri-operative, and infection management products. It sells its products directly and through independent distributors under the ColActive, ColActive PLUS, CovaWound, CovaView, CovaClear IV, IV Clear, SurgiClear, MediClear, and VALGuard brands. The company serves health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Financials
- Revenue (TTM)
- $34.35M
- EBITDA
- $4.05M
- Profit Margin
- 12.78%
- ROE (TTM)
- 14.33%
- EPS (Diluted)
- 0.16
- Book Value
- 1.14
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About COV
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TNX | TenX Protocols Inc. | $49.89 | +49790.00% |
| CZZ | Cleghorn Minerals Ltd | $0.12 | +91.67% |
| MEGO-P | Amego Capital Corp. | $0.07 | +50.00% |
| SNV | Sonoro Energy Ltd | $0.01 | +50.00% |
| ESBL | Eshbal Functional Food Inc. | $0.07 | +40.00% |
| ALT | Alturas Minerals Corp | $0.02 | +33.33% |
| HANS | Hanstone Gold Corp | $0.02 | +33.33% |
| ILC | ILC Critical Minerals Ltd. | $0.02 | +33.33% |
COV.V news timeline
9 articles covering COV.V, most recent first
LatestWhy Covalon Technologies Ltd. stock plummeted yesterday
September 2026
- What's Going On With Covalon Technologies Ltd. Stock Friday?
- What's Going On With Covalon Technologies Ltd. Stock Wednesday?
- Why Covalon Technologies Ltd. stock is near a 52-week high
- What's Going On With Covalon Technologies Ltd. Stock Wednesday?
- Why Covalon Technologies Ltd. stock is near a 52-week high
- Why Covalon Technologies Ltd. stock is near a 52-week high
- TSX & TSXV small caps leading the week — September 3, 2026